Discussion  by unknown
JOURNAL OF VASCULAR SURGERY
Volume 46, Number 2 Armstrong et al 195patients as these services remain billable (CPT codes
99371-3) and for patients requiring repair for AAA growth
during surveillance, documentation of intervention plan-
ning from CT images by the surgeon/operator is also
reimbursable (CPT G0288). Patients experiencing AAA
growth during surveillancemanaged “centrally” could then
be sent back to the referring/assigned providers and their
preferred vascular surgeon/“interventionalist” for appro-
priate AAA treatment. Other common pathological entities
that require serial imaging studies (eg, small pulmonary
nodules or low probability mammographic breast lesions)
could be “centrally” managed by similar surveillance meth-
ods with the resource “tools” described in this report.
Reduction in the variability of care quality, efficiency of
disease management, and improved patient compliance
may all result in safer outcomes.
CONCLUSION
Implementation of a clinical pathway for nonoperative
management of small AAA (4.0 to 5.4 cm) was associated
with high patient compliance, low rupture risk, and ex-
tremely low cumulative aneurysm-related mortality. Aneu-
rysm surveillance can be efficiently performed to achieve
optimal patient safety and could be associated with long-
term resource utilization and cost benefits.
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Dr Marc A. Passman (Nashville, Tenn). Drs Armstrong and
associates should be complimented on an excellent presentation
and well-written manuscript. Based on evidence-based guidelines
and as carryover from their participation in the ADAM trial, a
continued surveillance program was established at James A. Haley
Veterans Hospital in Tampa, Florida, in 1998 for ongoing obser-
vation of small 4.0- to 5.4-cm abdominal aortic aneurysms (AAA).
During the 8-year period, 473 patients were evaluated, of which
139 required operation for AAA exceeding 5.4 cm and 334 en-
tered the surveillance algorithm for AAA of 4.0 to 5.4 cm. For
those within the surveillance program, the authors report onlyaneurysm-related mortality of 0.9% for those following the
surveillance treatment algorithm. This leads me to several
questions.
First, with a captive VA population, a high compliance rate of
98.5% is reported with the surveillance algorithm, which included
CT or ultrasound imaging biannually. While such a compliance
rate is commendable, it may be more difficult to reproduce outside
the VA system. Although some recommendations are provided
based on their VA experience, do the authors have any additional
recommendations for success in the “real world,” where cost and
resources may be more problematic? After all, your group does not
have a comparable program in the university arm of your practice.
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the prevalence or incidence of AAA seems lower in this study than
what would be expected in the general population with a similar
risk profile, which suggests there are either patients with AAA who
are not coming to your attention for enrollment or AAA is being
under-diagnosed. Nationally, there is an increasing attention being
placed on screening for AAA. What measures have the authors
taken to combine their surveillance program with efforts at in-
creased patient and provider awareness in their VA system to
increase screening and identification of AAA, and thereby improve
enrollment into the treatment and surveillance algorithm?
Third, for patients with AAA in the 4.0- to 5.4-cm range
entering the surveillance program, 225 patients (67%) eventually
required operative repair for size exceeding 5.4 cm or expansion
exceeding 1cm/year, of which 143 (or approximately two thirds)
underwent open repair and 82 (approximately one third), endo-
vascular repair. With so many patients eventually requiring opera-
tion, was there any downside to delay now that the patients are
older in terms of increased medical comorbidities compared to
when they entered the program? How many of these patients were
originally an endovascular candidate when entering the surveil-
lance program but with AAA expansion are no longer?
Finally, the threshold size for operation used in the treatment
algorithm is based on evidence based guideline related mostly to
comparison of open repair and surveillance. While randomized
trials comparing endovascular repair and surveillance for small
AAA are still ongoing, early, nonrandomized data from our insti-
tution and others have suggested that endovascular repair of small
AAAs is safe with low risk. Given that 67% of the patients in the
surveillance program eventually required operation, were the au-
thors able to retrospectively identify any factors that predicted
expansion thereby supporting potential earlier AAA repair, espe-cially for those who are endovascular candidates? Again, I congrat-
ulate the authors on their fine presentation and thank the Society
for the privilege of discussing this paper.
Dr Paul A. Armstrong: In response to your first question,
making the transfer of a surveillance program from a socialized
system like the VA to private practice is indeed a challenge, but if
we approach the problem by thinking outside of the box we can
find some creative ways in which to create interest in these pro-
grams and defray cost; for example, regional societies and health
management systems can be petitioned by their members or be
coerced by cost savings to participate. Likewise, legislative pressure
can be levied on third-party payers and health care systems to
provide funding.
In answer to your next question, the primary care providers
within the VA system have a health maintenance menu they
complete at each patient visit. Beginning this year, there has been
an addition to that menu that will include eligibility criteria for
one-time abdominal aneurysm screening. This will provide a clin-
ical reminder, if you will, for our primary providers and likely
increase the effectiveness of aneurysm screening.
In this review, as in others supporting surveillance, aneurysm-
related mortality was a relatively infrequent event. However, we
know that despite operative repair preventing rupture, our older
patients continue to die of other advanced conditions. In this
series, we noted 21 cardiac and 10 cancer deaths within 3 years of
AAA repair; therefore, the question for considering earlier AAA
intervention is an important one. We did not perform a subset
analysis of aneurysm morphology to determine if smaller aneu-
rysms were more amenable to endovascular repair. Instead, we
followed the size and growth parameters of the pathway to deter-
mine final operative options. Thus, I feel this review does little to
support the concept of inviting earlier aneurysm repair.
